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Fourier-transform ion cyclotron resonance instrumentation is uniquely applicable to an
unusual new ion chemistry, electron capture dissociation (ECD). This causes nonergodic
dissociation of far larger molecules (42 kDa) than previously observed (,1 kDa), with the
resulting unimolecular ion chemistry also unique because it involves radical site reactions for
similarly larger ions. ECD is highly complementary to the well known energetic methods for
multiply charged ion dissociation, providing much more extensive protein sequence informa-
tion, including the direct identification of N- versus C-terminal fragment ions. Because ECD
only excites the molecule near the cleavage site, accompanying rearrangements are minimized.
Counterintuitively, cleavage of backbone covalent bonds of protein ions is favored over that of
noncovalent bonds; larger (.10 kDa) ions give far more extensive ECD if they are first
thermally activated. This high specificity for covalent bond cleavage also makes ECD
promising for studying the secondary and tertiary structure of gaseous protein ions caused by
noncovalent bonding. (J Am Soc Mass Spectrom 2001, 12, 245–249) © 2001 American
Society for Mass Spectrometry
Fourier-transform ion cyclotron resonance (FTICR)mass spectrometry [1] has revolutionized manyresearch areas of gaseous ion chemistry, as de-
scribed in other reviews of this special issue. Since 1984
our Cornell laboratory has used the unique FTICR
capabilities of high resolution, simultaneous data col-
lection, and tandem MS (MS/MS, MSn) for biomolecule
characterization [2]. Until recently, our FTICR research
in ion chemistry to provide primary structure informa-
tion has focused on the unimolecular dissociations of
ionized proteins and DNA using a variety of methods
for vibrational excitation. These include collisional acti-
vation [3], laser infrared multiphoton dissociation [4],
blackbody infrared dissociation [5], and surface in-
duced dissociation [6]. However, all of these result in
essentially the same unimolecular chemistry for large
biomolecules, as their unusually large number of vibra-
tional degrees of freedom must all be activated in the
“ergodic” energizing process, primarily dissociating
those bonds of lowest activation energy. Even photo-
dissociation of multiply charged protein ions with 193
nm photons (6.4 eV) from an excimer laser produces the
same cleavages [7]; the large amount of energy depos-
ited by a single photon is also randomized over the
many vibrational degrees of freedom before dissocia-
tion takes place. Substituents added in post-transla-
tional modifications, such as glycosylation, carboxyla-
tion, oxidation, and phosphorylation, often dissociate
with even lower activation energies than those of back-
bone cleavages [8]. Here we describe the new ion
chemistry resulting from electron capture dissociation
(ECD) of multiply charged cations [9] for which FTMS
provides ideal instrumentation. ECD is a nonergodic
technique [10] that thus not only provides information
on the primary protein structure that is highly comple-
mentary, but also information on secondary and ter-
tiary structure because ECD of noncovalent bonds is
unfavorable [9d].
Proteomics is suddenly a highly important research
area, resulting from the revolutionary elucidation of
DNA sequences of whole genomes. These, estimated to
be 80,000 for humans, encode the primary sequences of
the organism’s proteins. For this problem, mass spec-
trometry has shown great promise, with a “bottom up”
approach using mass spectrometry and MS/MS of low
(,2 kDa) MW proteolysis products [11] and a “top
down” approach of MSn of the protein and its larger
fragments [12].
Mass spectrometry identification of a specific residue
(amino acid) in a linear protein chain requires at least
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two mass values, one each from dissociation of the
bonds on either side of the residue, preferably a mass
representing a fragment that still contains one of the
termini [11, 12]. Because the conventional energizing
methods favor dissociation of the lowest energy bonds
[3–7], these methods seldom provide complete MS/MS
sequence information for proteins larger than 1 or 2
kDa. Chemical [11] or ion–molecule [13] modifications
can change the reactivity adjacent to specific amino
acids of a protein, but a general sequencing method
would require a multiplicity of such methods. Some
years ago it was suggested that neutralization of a
protonated site would form a hypervalent species that
should have an unusually low dissociation energy for
backbone protein cleavage [14]. However, all efforts to
exploit this new chemistry failed, only to find that
related chemistry was basic to the serendipitous discov-
ery of electron capture dissociation (ECD) [9]. Experi-
mental methodology for ECD will not be reviewed here,
as this has been covered in detail recently [9c, d].
Selective Radical Ion Chemistry of Large
Multiply Charged Ions
The energetic methods [3–7] for backbone dissociations
of multiply charged proteins almost all involve cleav-
age of the amide bond (eq 1) to form b, y ions. However,
after electron capture at a
protonated site to form a hypervalent species (eq 2), the
major ECD pathway involves N-alkyl bond cleavage
(eq 3) to form c, zz product ions, with a minor pathway
to form az , y ions (eq 4).
ECD ion chemistry is unique for large molecules in
that Hz capture produces an odd-electron ion
(OEn1z) leading to a radical site reaction; almost all “soft
ionization” techniques produce even-electron (EEn1)
large ions. For the small OEn1z ions formed by higher
energy (;70 eV) electron ionization (EI), such radical
site reactions have been extensively studied [15]. Their
far greater utility for structural characterization has
made EI MS the dominant method for identifying
“global” unknowns over many decades [16]. Thus the
main ECD reaction of protein ions (eq 3) parallels the
common “a-cleavage” reaction in that it “donates an
electron to form a new bond to an adjacent atom
concomitant with cleavage of another bond to that
atom, moving the radical site” [15]. Also the bond
dissociation energy for this OEn1z ion unimolecular
decomposition is far lower than that for the amine
NH–Ca cleavage of an EE
n1 ion [17–19].
Hz capture can also form another hypervalent species
by attack on a saturated heteroatom, followed by cleav-
age of another bond to the heteroatom (eq 4). This is
especially favored for disulfide bonds (eq 5), as these
have an unusually high hydrogen
atom affinity [9b]. ECD is especially useful for locating
posttranslational modifications of proteins because the
Hz affinity of the amide carbonyl is substantially higher
than that of common side chain modifications, such as
glycosylation, carboxylation, oxidation, and phosphor-
ylation [8]. However, if such hydroxy and ether oxy-
gens are the only hetero atoms present, as in polyeth-
ylene glycol ions, they can capture Hz and lead to ECD
of the hypervalent new species (eq 6) [20]. Polyester
multiply charged ions also capture
electrons, but at present this has led to minimal frag-
mentation. An important, and obvious, limitation to
this ion chemistry is that ECD is not applicable to
negative ions or to singly charged positive ions.
Additional Selectivity through
Nonergodic Dissociation
Removing the unpaired electron from this multiply
charged ion should require 5–7 eV of energy; con-
versely, the electron addition that formed this hyperva-
lent species should also add 5–7 eV of energy. Random-
ization of this energy over the thousands of degrees of
freedom of a large protein ion would result in only
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millivolts of excitation per bond. However, the unusual
proportion of backbone bonds cleaved (eqs 3 and 4),
plus extensive other evidence [9], indicates that these
cleavages are nonergodic, caused by this large addition
of energy before it is randomized away from the
reaction site. The recent scientific breakthroughs of
femtosecond spectroscopy have greatly popularized
these reactions that take place in such a time domain,
but nonergodic dissociations have previously been
studied only for small molecules, with the acetone1z as
the largest ion exhibiting this dissociation [10].
The electron captured may initially form a high
Rydberg state, which then undergoes surface crossing
involving an initial lowest energy geometry of the
protonated amine and amide carbonyl to yield the final
state reactants of eqs 3 and 4 [9b, c]. This surface
crossing to form c, zz ions converts the carbonyl double
bond to a nominal single bond, so that there should be
a substantial Franck–Condon factor that also favors
nonergodic cleavage. Despite the infrequent H1 solva-
tion to a disulfide (eq 6) in a dynamic protein ion, this
crossing should be far more favorable, as S–S has a far
higher Hz atom affinity. ECD of a 10 kDa protein with
one –S–S– bond gave only products from cleavage of
that bond [9b].
Thus capture of one electron cleaves only one cova-
lent bond. Capture of a second electron by an ECD
product is only observed with nearly complete reduc-
tion of the precursor ion [9d], as the e2 capture cross
section is proportional to the square of the charge. This
makes negligible any rearranged products due to ECD
cleavage of the two bonds, such as
[CH3(C2H4O)xCH3 1 nH]
n1 3 [CH3(C2H4O)yCH3 1
nH]n1 with loss of internal monomer units, while .20%
of CAD products show this rearrangement. This is
uniquely useful for MS/MS characterization of sepa-
rated copolymer oligomer formulas of only 0.5% rela-
tive abundance [21].
Because ECD occurs without an appreciable increase
in the average internal energy of the molecule, there is
little cleavage at sites of low Hz affinity, even at hydro-
gen bonds and other weak noncovalent bonds that are
the basis for the secondary and tertiary conformational
structure in the ions [22]. Ergodic backbone dissociation
methods [3–7] that add energy randomly over the ion
dissociate the noncovalent bonds first [22, 23], eliminat-
ing the secondary/tertiary structure. However, this
extra cyclic structure is a problem for sequencing by
ECD, as backbone cleavage will not produce two lower
mass products if they are still held together by such
noncovalent bonds. Normal ECD has not produced
fragment ions in protein ions that are larger than ;20
kDa [9a–c]. However, combining ECD with conven-
tional collisional [3, 6] or infrared [4, 5] activation gives
extensive “Activated Ion” (AI) ECD spectra for protein
ions as large as 42 kDa, and increases the number of
cleavages of apo-myoglobin ions (17 kDa) from 33 to 99
[9d].
Conformational Characterization
As a silver lining to this cloudy nature of ECD, the
difference between a conventional and AI ECD spec-
trum of the same ions must mainly arise from the ions’
conformational structure. Research in progress [24] is
finding that these ECD differences can provide unique
secondary/tertiary structural details for a number of
protein ions. For example, ECD spectra are effected
dramatically by BIRD [5] at different temperatures or
IRMPD [4]. Fast (,1 s) unfolding by laser IR irradiation
makes possible the measurement of refolding kinetics
of half lives of seconds to minutes [25]. In addition, ECD
characterization of noncovalent intermolecular adducts
formed by ESI should provide important information
on the similarity of their solution and gas phase struc-
tures, on which a variety of opinions have been ex-
pressed [22, 26].
Extensive Backbone Bond Cleavage of
Proteins
A good correlation is observed between the site of ECD
and hydrogen atom affinity [9]. In the absence of higher
affinity species, such as S–S bonds (eq 5) or Fe31, or
local stabilization by noncovalent bonding (vide supra)
[9d], there is surprisingly little difference in the ECD
cleavage tendencies of the common amino acids [17],
consistent with comparable Hz affinities for most amide
carbonyl groups (eq 3). Exceptions are the C-terminal
side of Trp, with a higher tendency because of its
3-alkylindole side chain [9b], and the N-terminal side of
Pro, which does not separate into products after under-
going eq 3 because of the remaining bond due to its cyclic
structure [9] (it can yield az , y products by eq 4, however).
This great advantage of ECD in producing a very
large number of products brings with it the instrumen-
tal challenge of measuring a far greater number of mass
values. Producing c and zz product ions from cleavages
between all residues of a 101 amino acid protein (;12
kDa) would yield 200 different isotopic clusters, plus
those from az , y products and products formed in other
charge states. Fortunately, FTICR has unique capabili-
ties for simultaneous ion measurements. Our 6 tesla
instrument with the THRASH data reduction program
[18] has, for example, provided mass values for nearly
400 isotopic clusters from an ECD spectrum of the
104-residue cytochrome c; more than 800 were provided
from an ESI spectrum measured on the 9.4 tesla Mar-
shall instrument [12d]. Thus a basic limitation to the
extent of sequence information in larger proteins is the
signal/noise (S/N) achieved for the determinant frag-
ment ions. Multiple spectra are an aid to this problem;
relative ECD product abundances are a function of
charge state [9], secondary/tertiary structure (gaseous
noncovalent bonding), and electron current [9d], so that
several ECD (and CAD) spectra measured under differ-
ent conditions provide more extensive sequence infor-
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mation, as well as improved S/N. Product ions repre-
senting cleavages between all 76 amino acids of
ubiquitin (8.6 kDa) were found in two ECD and one
CAD spectrum; submitting all these data to a de novo
sequencing algorithm [19] resulted in the correct pri-
mary structure. Conventional and activated ion (AI)
[9d] ECD and CAD spectra of cytochrome c showed
cleavages between all but 9 of its 103 amino acid pairs,
most of these in K13–V20 region that contains the Fe
31
heme cyclic (14–17) side chain whose Hz affinity is ;20
kcal/mol higher than that of the amide carbonyl [9b].
The S/N problem is epitomized in the AI ECD
spectrum of the 43 kDa thiaminase, a mixture of 379,
380, and 381 residue proteins [9d]. To obtain many
fragment ions of appreciable S/N requires electron
irradiation until essentially all molecular ions are re-
moved; as the number of products increases, their mass
values decrease. Although the largest ECD products are
c49 and zz79, the ECD spectra define 55 cleavages in these
terminal regions, including the sequence A14 to W33,
except for the D–P22 doublet. Although the lack of
products representing the central 69% of the protein
could be due to insufficient ion activation to break its
noncovalent bonding, the larger, more highly charged
products must also be undergoing secondary electron
capture (whose cross section is dependent on the square
of the charge), with the process repeated to accumulate
small terminal c and zz products of sufficient S/N.
Secondary e2 capture of a c (or zz) ion forms another c
(or zz) ion plus an internal (i) ion. Such i ions are not
found even in ECD spectra of peptides [17b]; although
the AI ECD spectra of large proteins use far higher e2
currents, the probability of forming a specific i ion is far
lower (formed by two cleavages, each with a probability
of ;1/380). This plethora of i products could account
for the continuum of near-background peaks of unit m/z
spacing over m/z 900–1500 in some AI ECD spectra [9d].
Thus higher field FTICR instruments that can store and
measure more ions should provide even more ECD
sequence information for large proteins.
A serious problem in using MS/MS data from con-
ventional energetic dissociation methods is assigning
mass values as b, y, or i ions. ECD spectra do not
contain appreciable i ions (vida supra), and the less
abundant az, y products (eq 4, and often the b, y eq 1
products) usually involve cleavages between the same
amino acids as those yielding c, zz products. These
coincidences (“golden complementary sets”) do pro-
vide sequence ordering information. For products
formed by cleavage between the same amino acids,
zz 2 y 5 216.02 Da, c 2 b 5 117.03 Da, and c 2 az 5
144.02 Da (this can also be CO2 loss), as set forth in
detail in the description of the sequencing algorithm
[19]. For example, if a complementary c, zz ion pair
(products whose masses sum to that of the molecule) is
accompanied by an ion of whose mass is 17.03 Da more
than that of one of the pair, that one is a zz ion and the
accompanying ion is a y. ECD, especially AI ECD,
spectra often contain b, y pairs from adventitious CAD;
such pairs are similarly valuable for ordering c, zz com-
plementary pairs [19]. For .20 kDa proteins, no com-
plementary ECD fragment mass pairs are observed;
even without these, the 216.02 and 117.03 Da mass
differences can provide terminal assignments of good
confidence. Also, any assignment as N- or C-terminal to
a partial sequence automatically provides the opposite
assignment to a second partial sequence containing
overlapping mass values.
Sequence Tags
The proteomics explosion has greatly increased the
need for the identification of proteins expressed from
genes of known DNA sequence. MS is proving invalu-
able for this, but generally requires purification (2-D
gels) to relatively high purity, digestion to small pep-
tides, with mass spectrometry molecular weight deter-
mination. If these values do not retrieve a confident
protein assignment from the database, MS/MS of one
or more peptide ions is used to generate “sequence
tags” [27a] for database retrieval. ECD offers a powerful
alternative that should require less rigorous initial pro-
tein separation (e.g., capillary electrophoresis, capillary
liquid chromatography), no proteolysis, with only CAD
[27b] or ECD of the mass spectrometry-separated mo-
lecular ions from ESI of a mixture containing several
proteins. AI ECD [9d] of carbonic anhydrase (29 kDa,
259 residues) gave nine sequence tags of six or more
residues, with the largest of 16 residues. The largest for
thiaminase contained 10 N-terminal residues, despite
the S/N reduction due to formation of these c ions from
379, 380, and 381 amino acid proteins.
Conclusions
To date, ECD of large molecules has been implemented
only with FTICR instrumentation [9c]; this is conceiv-
able with other common mass spectrometry instru-
ments, but overall ECD performance superior to FT-ICR
appears doubtful. It is especially notable that ECD has
greatly expanded the unimolecular chemistry of large
multiply charged positive ions. Now odd-electron ions
can be formed, and the extensive knowledge of small
OE1z ion chemistry [15] should be extendable to pro-
vide both new ionic reactions and new characterization
capabilities for bio- and other macromolecules; copoly-
mers appear to be a particularly promising application
[20, 21]. For basic physical chemistry of ions, further
investigation of the unique ECD mechanisms that ap-
pear to involve initial formation of a high Rydberg state
and nonergodic dissociation, could greatly expand
knowledge in this important research frontier. Finally,
for the sudden critical importance of proteomics, ECD
appears to provide a powerful new method for protein
identification, correction of DNA sequence errors, char-
acterization of post-translational modifications, and
even de novo sequencing.
248 MCLAFFERTY ET AL. J Am Soc Mass Spectrom 2001, 12, 245–249
Acknowledgments
We thank Barbara Baird, Tadhg Begley, Einar Fridriksson, Neil
Kelleher, Nathan Kruger, Stone D.-H. Shi, and Julian Whitelegge
for valuable discussions, and the National Institutes of Health
(grant GM-16609) for generous funding.
References
1. Comisarow, M. B.; Marshall, A. G. Chem. Phys. Lett. 1974, 25,
282–283. White, R. L.; Ledford, E. B.; Ghaderi, S.; Wilkins, S. L.;
Gross, M. L. Anal. Chem. 1980, 52, 1525. Karlin, T. J.; Freiser,
B. S. Anal. Chem. 1983, 55, 571–574. Castro, M. E.; Russell, D. H.
Anal. Chem. 1984, 56, 578. Hunt, D. F.; Shabanowitz, J.; McIver,
R. T., Jr.; Hunter, R. L.; Syka, J. E. P. Anal. Chem. 1985, 57,
765–768. Marshall, A. G.; Wang, T. C. L.; Chen. L.; Ricca, T. L.
ACS Symp. Ser. 1987, 359, 21–33. Fourier-Transform Mass Spec-
trometry; Buchanan, M. V. Ed.; American Chemical Society:
Washington, DC, 1987. Wilkins, C. L.; Chowdhury, A. K.;
Nuwaysir, L. M.; Coates, M. L. Mass Spectrom Rev. 1989, 8,
67–92. Marshall, A. G.; Grosshans, P. B. Anal. Chem. 1991, 63,
A215–A229. Beu, S. C.; Laude, D. A., Jr. Int. J. Mass Spectrom.
Ion Processes 1992, 112, 215–230. Hofstadler, S. A.; Laude, D. A.,
Jr. J. Am. Soc. Mass Spectrom. 1992, 3, 615–623. Hofstadler, S. A.;
Beu, S. C.; Laude, D. A., Jr. Anal Chem. 1993, 65, A245–A259.
Winger, B. E.; Hofstadler, S. A.; Bruce, J. E.; Udseth, H. R.;
Smith, R. D. J. Am. Soc. Mass Spectrom. 1993, 4, 566–577.
Williams, E. R. Anal Chem. 1998, 70, 179A–185A. Marshall
A. G.; Hendrickson, C. L; Jackson, G. S. Mass. Spectrom. Rev.
1998, 17, 1–36.
2. Cody, R. B., Jr.; Amster, I. J.; McLafferty, F. W. Proc. Natl. Acad.
Sci. U.S.A., 1985, 82, 6367–6370. McLafferty, F. W.; Amster, I.
J; Furlong, J. J. P.; Loo, J. A.; Wang, B. H.; Williams, E. R.
Tandem Fourier-Transform Mass Spectrometry; M. V. Buchanan,
Ed.; American Chemical Society: Washington, DC, 1987.
Henry, K. D.; Williams, E. R.; Wang, B. H.; McLafferty, F. W.;
Shabanowitz, J.; Hunt, D. F. Proc. Natl. Acad. Sci. U.S.A., 1989,
86, 9075–9078. Beu, S. C.; Senko, M. W.; Quinn, J. P.; Wampler,
F. M., III; McLafferty, F. W. J. Am. Soc. Mass Spectrom., 1993, 4,
557–565. Senko, M. W.; Beu, S. C.; McLafferty, F. W. Annu. Rev.
Biophys. Biomol. Struct. 1994, 23, 763–785.
3. (a) Loo, J. A.; Udseth, H. R.; Smith, R. D. Rapid Commun. Mass
Spectrom. 1988, 2, 207–210. (b) Gauthier, J. W.; Trautman, T. R.;
Jacobsen, D. B. Anal. Chim. Acta 1991, 246, 211–225. (c) Senko,
M. W.; Speir, J. P.; McLafferty, F. W. Anal. Chem. 1994, 66,
2801–2808.
4. Little, D. P.; Chorush, R. A.; Speir, J. P.; Senko, M. W.; Kelleher,
N. L.; McLafferty, F. W. J. Am. Chem. Soc. 1994, 116, 4893–4897.
5. Price, W. D.; Schnier, P. D.; Williams, E. R. Anal Chem. 1996, 68,
859–866.
6. (a) McCormack, A. L.; Jones, J. L.; Wysocki, V. H. J. Am. Soc.
Mass Spectrom. 1992, 3, 859–862. (b) Chorush, R. A.; Little,
D. P.; Beu, S. C.; Wood, T. D.; McLafferty, F. W. Anal. Chem.
1995, 67, 1042–1046.
7. Guan, Z.; Kelleher, N. L.; O’Connor, P. B.; Aaserud, D. J.;
Little, D, P.; McLafferty, F. W. Int. J. Mass Spectrom. Ion
Processes 1996, 157, 357–364.
8. (a) Mirgorodskaya, E.; Roepstorff, P.; Zubarev, R. Anal. Chem.
1999, 71, 4431–4436. (b) Kelleher, N. L.; Zubarev, R. A.; Bush,
K.; Furie, B.; Furie, B. C.; McLafferty, F. W.; Walsh, C. T. Anal.
Chem. 1999, 71, 4250–4253. (c) Fridriksson, E. K.; Beavil, A.;
Holowka, D.; Gould, H. J.; Baird, B.; McLafferty, F. W.
Biochemistry 2000, 39, 3369–3376. (d) Schey, K. L.; Finley, E. L.
Acc Chem. Res. 2000, 33, 299–306. (e) Shi, S. D.-H.; Hemling,
M. E.; Carr, S. A.; Horn, D. M.; Lindh, I.; McLafferty, F. W.
Anal. Chem., submitted.
9. (a) Zubarev, R. A.; Kelleher, N. L.; McLafferty, F. W. J. Am.
Chem. Soc. 1998, 120, 3265–3266. (b) Zubarev, R. A.; Kruger,
N. A.; Fridriksson, E. K.; Lewis, M. A.; Horn, D. M.; Carpenter,
B. K.; McLafferty, F. W. J. Am. Chem. Soc. 1999, 121, 2857–2862.
(c) Zubarev, R. A.; Horn, D. M.; Fridriksson, E. K.; Kelleher,
N. L.; Kruger, N. A.; Lewis, M. A.; Carpenter, B. K.; McLaf-
ferty, F. W. Anal. Chem. 2000, 72, 563–573. (d) Horn, D. M.; Ge,
Y.; McLafferty, F. W. Anal. Chem., 2000, 72, 4778–4784.
10. Turecek, F.; McLafferty, F. W. J. Am. Chem. Soc. 1984, 106,
2525–2528.
11. (a) Biemann, K. In Methods in Enzymology; McCloskey, J. A.,
Ed.; Academic: San Diego, 1990; Vol. 193, p 887. (b) Andersen,
J. S.; Svensson, B.; Roepstorff, P. Nature Biotechnol. 1996, 14,
449–457. (c) Qin, J.; Chait, B. T. Anal. Chem. 1997, 69, 4002–
4009. (d) Kuster, B.; Mann, M. Curr. Opin. Chem. Biol. 1998, 8,
393–400. (e) Jensen, K.; Pasa-Tolic, L.; Anderson, G. A.; Hor-
ner, J. A.; Lyston, M. S.; Bruce, J. E.; Smith, R. D. Anal. Chem.
1999, 71, 2076–2084.
12. (a) McLafferty, F. W. Acc. Chem. Res. 1994, 27, 379–386. (b)
McLafferty, F. W.; Kelleher, N. L.; Begley, T. P.; Fridriksson,
E. K.; Zubarev, R. A.; Horn, D. M. Curr. Opin. Chem. Biol. 1998,
2, 571–578. (c) Kelleher, N. L.; Lin, H. Y.; Valaskovic, G. A.;
Aaserud, D. J.; Fridriksson, E. K.; McLafferty, F. W. J. Am.
Chem. Soc. 1999, 121, 806–812. (d) McLafferty, F. W.; Fridriks-
son, E. K.; Horn, D. M.; Lewis, M. A.; Zubarev, R. A. Science
(Washington, D. C.) 1999, 284, 1289–1290.
13. Green, M. K.; Lebrilla, C. B. Mass. Spectrom. Rev. 1997, 16,
53–72. Brodbelt, J. S. Mass Spectrom Rev. 1997, 16, 91–110.
Ranatunga, T. D.; Kennady, J. M.; Kenttamaa, H. I. J. Am.
Chem. Soc. 1997, 119, 5200–5207. McLuckey, S. A.; Stephenson,
J. L. Mass Spectrom. Rev. 1998, 17, 369–407.
14. McLafferty, F. W. In Mass Spectrometry in the Analysis of Large
Molecules; McNeal, C. J., Ed.; Wiley: New York, 1986, pp 107–120.
15. McLafferty, F. W.; Turecek, F. In Interpretation of Mass Spectra,
4th ed. University Science Books: Mill Valley, CA, 1993.
16. McLafferty, F. W.; Stauffer, D. A.; Loh, S. Y.; Wesdemiotis, C.
J. Am. Soc. Mass Spectrom. 1999, 10, 1229–1240.
17. (a) Kruger, N. A.; Zubarev, R. A.; Carpenter, B. K.; Kelleher,
N. L.; Horn, D. M.; McLafferty, F. W. Int. J. Mass Spectrom.
1999, 182, 1–5. (b) Kruger, N. A.; Zubarev, R. A.; Horn, D. M.;
McLafferty, F. W. Int. J. Mass Spectrom. 1999, 185, 787–793.
18. Horn, D. M.; Zubarev, R. A.; McLafferty, F. W. J. Am. Soc. Mass
Spectrom. 2000, 11, 320–332.
19. Horn, D. M.; Zubarev, R. A.; McLafferty, F. W. Proc. Natl. Acad.
Sci. U.S.A., 2000, 97, 10313–10317.
20. Cerda, B. A.; Horn, D. M.; Breuker, K.; Carpenter, B. K.;
McLafferty, F. W. Eur. Mass Spectrom. 1999, 5, 335–338.
21. Cerda, B. A.; Horn, D. M.; Breuker, K.; McLafferty, F. W. J. Am
Chem. Soc., submitted.
22. McLafferty, F. W.; Guan, Z.; Haupts, U.; Wood, T. D.; Kelleher,
N. L. J. Am. Chem. Soc. 1998, 120, 4732–4740.
23. Speir, J. P.; Senko, M. W.; Little, D. P.; Loo, J. A.; McLafferty,
F. W. J. Mass Spectrom. 1995, 30, 39–42. Little, D. P.; McLaf-
ferty, F. W. J. Am. Soc. Mass Spectrom. 1996, 7, 209–210.
Fridriksson, E. K.; Baird, B.; McLafferty, F. W. J. Am. Soc. Mass
Spectrom. 1999, 10, 453–455.
24. Horn; D. M.; Breuker, K.; Cerda, B. A.; Ge, Y.; McLafferty,
F. W., unpublished.
25. Horn, D. M.; Breuker, K.; Frank, A. J.; McLafferty, F. W. J. Am.
Chem. Soc., submitted.
26. Ganem, B.; Li, Y. -T.; Henion, J. D. J. Am. Chem. Soc. 1991, 113,
6294–6296. Li, Y.-T.; Henion, J. D.; Senko, M. W.; McLafferty,
F. W.; Ganem, B. J. Am. Chem. Soc. 1993, 115, 8409–8413. Loo,
J. A. Mass Spectrom. Rev. 1997, 16, 1–23.
27. Mann, M.; Wilm, M. Anal. Chem. 1994, 66, 4390–4399. Mortz,
E.; O’Connor, P. B.; Roepstorff, P.; Kelleher, N. L.; Wood, T. D.;
McLafferty, F. W.; Mann, M. Proc. Natl. Acad. Sci. U.S.A. 1996,
93, 8264–8267.
249J Am Soc Mass Spectrom 2001, 12, 245–249 ELECTRON-CAPTURE DISSOCIATION BY FTICR
